Mission Bio: transforming single-Cell DNA analysis

FUSION GENOMICS: a new era in pathogen sequencing

GenomeDx improves cancer and urology patient care

Developing treatments for rare genetic diseases

The rare disease therapy was developed by Modis Therapeutics. This company is based on Columbia University research. Modis Therapeutics was formed through a collaboration with academic experts in mitochondrial biology to develop disease-modifying therapies for rare genetic diseases. The company completed a series A financing with investments from F-Prime Capital Partners, OrbiMed, Aceras Life Sciences, and Osage University Partners. The company has assembled a management team with deep experience in the development of high-impact products for serious diseases at leading biotech and pharmaceutical companies. Modis is a dedicated team, passionate about bringing novel therapies to patients with uncommon diseases.

by
3 days ago

Bio-engineered liver tissue and liquid cornea

Exclusive interview for SPINOFF.COM with Dr. Tuhin Bhowmick, the director and co-founder of Pandorum Technologies Pvt. Ltd, about their 3D tissue engineering technology. Pandorum Technologies Pvt. Ltd is a Bangalore based biotechnology company with the focus on tissue engineering and regenerative medicine. With its distinct synergy of life science, engineering, and clinical competencies, the company designs and manufactures three-dimensional functional human tissues, intended for medical research and therapeutics. Pandorum Technologies believes in the development and dissemination of high-end innovations aimed at addressing the most important challenges in healthcare. They are dedicated to using the scientific and technological prowess to elevate the quality and extend human life. 

by
3 days ago

Proteus Digital Health creats a new category of pharmaceuticals

Digital Medicine that measures medication treatment effectiveness and helps physicians improve clinical outcomes was developed by Proteus Digital Health. Armed with more than 450 issued patents and led by some of the brightest minds in technology, pharmaceuticals and healthcare, the company has invented Digital Medicine, a new category of pharmaceuticals. Together, with leading health systems and pharmaceutical companies, the company is bringing this new digital solution to healthcare providers, thereby increasing access to better insight, optimized therapies and lower costs. The executive team and board of directors guide Proteus based on their depth of expertise across life sciences, consumer technology and capital markets.

by
3 days ago

The new technology could help lead to better disease diagnosis and screening

Investment

Preventing stroke at home

Investment

Artificially cultured meat

A new benchmark in cell-grown meat

Aleph Farms, Technion-Israel Institute (Technion) spinoff company,  has developed a technology for creating steak from a few cow cells in a bioreactor. Aleph Farms' clean meat is closer to free-range meat due to a proprietary approach that focuses on directly growing the edible part of the animal in 3D using four types of cells, ensuring an end product that resembles the taste, texture, and structure of farmed meat.  Cell-grown meat technology is gaining interest for its promise of production of slaughter-free meat, without the need for devoting vast tracts of land, water, feed and other resources to raise cattle. This comes at a time when the adverse impacts of climate change and the effects on agriculture and livestock sectors, is under the spotlight.  Cell-grown meat is typically grown from a few cells of a living animal, extracted painlessly. These cells are nourished and grow to produce a complex matrix that replicates muscle tissue.

by
3 days ago

AVIRU develops the novel drug for the treatment of bacterial infections

AVIRU GmbH is a spinoff from the Center for Integrated Protein Science Munich excellence cluster and its laboratories are located at TUM in Garching. The company specializes in developing small molecules to fight bacterial pathogens and parasites. The demand for alternative therapies to antibiotics is rapidly increasing. For decades, the spread of resistance and multi-drug resistant pathogens (e.g., MRSA) have threatened the efficacy of traditional antibiotics. AVIRU combats this lack of new treatment approaches with novel active ingredient candidates and a revolutionary mechanism of action.

by
3 days ago

A metabolic compound that regulates growth of rice plants

A new metabolite that promotes growth in rice plants and thwarts infestation by a common parasitic plant could help improve global food security has been developed by the researchers at KAUST. Plant scientists are working on methods for generating healthy, nutritious crops to feed the world’s growing population. However, breeding strong plants that provide reliable, sustainable yields is beset with challenges, including battling parasitic infestations and plant infections. Apocarotenoids are organic compounds found in the tissues of most living things; they can act as hormones and signaling molecules which, among other functions, stimulate metabolic processes. Scientists are just beginning to untangle the complex networks of these compounds in plants, with surprising results.

by
3 days ago

Cookies help us deliver our Services. By using our website or clicking I agree, you agree to our use of cookies. Learn more about our cookie and privacy policy.

I AGREE

#1 VENTURE CLIENT PLATFORM